CoChat

Adrenoleukodystrophy: Biochemical procedures in diagnosis, prevention and treatment

Watkins, P. A., Naidu, S., Moser, H. W. · 1987 · Journal of Inherited Metabolic Disease

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

The childhood form of adrenoleukodystrophy is an X‐linked recessive disorder which is characterized biochemically by elevated concentrations of saturated very long chain fatty acids in tissues and plasma and impaired very long chain fatty acid oxidation in fibroblasts and leukocytes from adrenoleukodystrophy patients. The most consistently observed increase is that in hexacosanoic acid (C26:0); thus, measurement of plasma C26:0 concentration by gas‐liquid chromatography provides a rapid, sensitive method of diagnosis. Prenatal diagnosis of adrenoleukodystrophy can be made by measurement of C26:0 concentrations in amniocytes and chorionic villus cells. Heterozygote (carrier) detection has also been accomplished by biochemical measurement of C26:0 in plasma and skin fibroblasts. In a study of over 200 obligate heterozygotes, >90% showed abnormal concentrations of C26:0. Hybridization studies using the cloned DNA fragment St14 detects polymorphisms in the distal end of the long arm of the X chromosome (Xq27–28) and six informative kindreds have shown co‐segregation of adrenoleukodystrophy and the St14 marker through 65 meioses. Thus, such studies can supplement very long chain fatty acid concentrations in heterozygote detection. Therapeutic interventions for adrenoleukodystrophy, such as dietary restriction of very long chain fatty acids, administration of clofibrate or carnitine, immunosuppression and adrenal hormone replacement, have not been successful. Recently, a modification of the very long chain fatty acid‐restricted diet has been employed in which this diet is supplemented with synthetic glycerol trioleate. The rationale for this diet is that decreased very long chain fatty acid synthesis by fibroblasts from patients with adrenoleukodystrophy was observed when oleic acid was added to the culture medium. In a study of 14 patients on this diet from 2 to 11 months, there was a mean reduction in plasma C26:0 levels of 46%, with one patient achieving a normal plasma level. The effect of lowering plasma very long chain fatty acid concentrations on the neurologic status of patients with adrenoleukodystrophy and on the development of symptoms in asymptomatic individuals with elevated very long chain fatty acid concentrations remains to be established.

Overview

Integrity signals

Registry

Crossref · 10.1007/bf01812846

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Moser H. W. Naidu S. Kumar A. J.andRosenbaum A. E.The adrenoleukodystrophies.Crit. Rev. Neurobiol.(1986b) in press.

Cited by

See all 20

Metadata

Authors
Watkins, P. A., Naidu, S., & Moser, H. W.
Affiliations
Johns Hopkins University (US)
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
1987-03
Volume
10
Issue
S1
Pages
46-53
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W2075066897
Cited by
20
References
20
Citations by year
2023: 1 · 2021: 2 · 2020: 1 · 2016: 1 · 2014: 2
FWCI
1.40
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Inherited Metabolic Disease (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
Keywords
adrenoleukodystrophy, very long chain fatty acids, hexacosanoic acid, X-linked recessive disorder, prenatal diagnosis, carrier detection, dietary restriction, triolein, oleic acid, clofibrate, L-carnitine, diagnosis, treatment
MeSH terms
Adrenoleukodystrophy, Diffuse Cerebral Sclerosis of Schilder, Child, Chromosome Mapping, Fatty Acids, Female, Genetic Carrier Screening, Humans, Phenotype, Pregnancy, Prenatal Diagnosis, X Chromosome, Bone Marrow Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.